{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5281915",
      "entity_text" : "CoQ10",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5939",
      "entity_text" : "biguanide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The classic diabetic patient is on a biguanide and or sulfonylurea which both inhibit CoQ10 (XREF_TABLE) and have shown to cause neuropathy.",
  "reading_complete" : "2020-08-03T16:28:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:22:26Z",
  "trigger" : "inhibit",
  "evidence" : [ "biguanide and or sulfonylurea which both inhibit CoQ10" ],
  "pmc_id" : "6327261",
  "score" : 0
}